B Müller
Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance
Dusemund F, Carre E, Schuetz P, Gaillat J, Regez K, Bossart R, Schild U, Müller B, Albrich W, Hausfater P, Amin D, Schwietert M, Bucher B, Meyer S, Thomann R, Kühn F, Bassetti S, Sprenger M, Baechli E, Sigrist T, ProREAL Study Team. Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance. Eur J Clin Microbiol Infect Dis 2012; 32:51-60.
12.08.2012Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance
12.08.2012Eur J Clin Microbiol Infect Dis 2012; 32:51-60
Dusemund F, Carre E, Schuetz P, Gaillat J, Regez K, Bossart R, Schild U, Müller B, Albrich Werner, Hausfater P, Amin D, Schwietert M, Bucher B, Meyer S, Thomann R, Kühn F, Bassetti S, Sprenger M, Baechli E, Sigrist T, ProREAL Study Team
Optimised patient transfer using an innovative multidisciplinary assessment in Kanton Aargau (OPTIMA I): an observational survey in lower respiratory tract infections
Albrich W, Reutlinger B, Huber A, Sigrist T, Schuetz P, Conca A, Schild U, Regez K, Bossart R, Dusemund F, Rüegger K, Müller B. Optimised patient transfer using an innovative multidisciplinary assessment in Kanton Aargau (OPTIMA I): an observational survey in lower respiratory tract infections. Swiss Med Wkly 2011; 141:w13237.
30.07.2011Optimised patient transfer using an innovative multidisciplinary assessment in Kanton Aargau (OPTIMA I): an observational survey in lower respiratory tract infections
30.07.2011Swiss Med Wkly 2011; 141:w13237
Albrich Werner, Reutlinger B, Huber A, Sigrist T, Schuetz P, Conca A, Schild U, Regez K, Bossart R, Dusemund Frank, Rüegger K, Müller B
Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey
Schuetz P, Batschwaroff M, Dusemund F, Albrich W, Bürgi U, Mäurer M, Brutsche M, Huber A, Müller B. Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey. Eur J Clin Microbiol Infect Dis 2009; 29:269-77.
29.12.2009Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey
29.12.2009Eur J Clin Microbiol Infect Dis 2009; 29:269-77
Schuetz P, Batschwaroff M, Dusemund Frank, Albrich Werner, Bürgi U, Mäurer M, Brutsche M, Huber A R, Müller B
MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma
Kempf W, Kutzner H, Cozzio A, Sander C, Pfaltz M, Müller B, Pfaltz M. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Br J Dermatol 2008; 158:1280-7.
10.04.2008MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma
10.04.2008Br J Dermatol 2008; 158:1280-7
Kempf W, Kutzner H, Cozzio Antonio, Sander C A, Pfaltz M C, Müller B, Pfaltz M
Women with polycystic ovary syndrome are sensitive to the TNF-alpha-lowering effect of glucose-induced hyperinsulinaemia
Puder J, Varga S, Nusbaumer C, Zulewski H, Bilz S, Müller B, Keller U. Women with polycystic ovary syndrome are sensitive to the TNF-alpha-lowering effect of glucose-induced hyperinsulinaemia. European journal of clinical investigation 2006; 36:883-9.
01.12.2006Women with polycystic ovary syndrome are sensitive to the TNF-alpha-lowering effect of glucose-induced hyperinsulinaemia
01.12.2006European journal of clinical investigation 2006; 36:883-9
Puder J J, Varga S, Nusbaumer C P G, Zulewski H, Bilz Stefan, Müller B, Keller U